Hirano, Ikuo, Dellon, Evan S., Peterson, Kathryn, Talley, Nicholas J., Bierdermann, Luc, von Arnim, Ulrike, Savarino, Edoardo V., Schlag, Christoph, Wershil, Barry K., Menard-Katcher, Calies, Muir, Amanda B., Wechsler, Joshua B., Falk, Gary W., Chehade, Mirna, Spergel, JM, Atkins, D, Oliva, S, Arva, NC, Guang-Yu, Y, Jensen, ET, Safroneeva, E, Ackerman, S, Gupta, SK, Gonsalves, Nirmala P., Rothenberg, M, Katzka, D, Pletneva, M, Wright, BL, Hiremath, G, Klion, A, Attwood, S, Bonis, P, Aceves, S, Ghisa, M, Furuta, Glenn T., Miehlke, S, Vanuytsel, T, Woodland, G, Thomas, G, Kuang, FL, Bredenoord, Albert J., Assessment of Clinical endpoints in Eosinophilic esophagitis for Novel Therapeutics (ASCENT) working group,, Straumann, Alex, Schoepfer, Alain, Chang, Joy W.. Elsevier; 2024. Ascending to new heights for novel therapeutics for eosinophilic esophagitis.